Receptor-targeted nanoparticles for in vivo imaging of breast cancer. - Wikidata - awgldk - TriplyDB

Receptor-targeted nanoparticles for in vivo imaging of breast cancer.

Receptor-targeted nanoparticles for in vivo imaging of breast cancer.

http://www.wikidata.org/entity/Q37307237

about

Nanoparticle-facilitated functional and molecular imaging for the early detection of cancer Urokinase-type plasminogen activator receptor (uPAR) as a promising new imaging target: potential clinical applications Assembly of linear nano-chains from iron oxide nanospheres with asymmetric surface chemistry Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.Photoacoustic and fluorescence image-guided surgery using a multifunctional targeted nanoprobe.Leptin-Notch signaling axis is involved in pancreatic cancer progression Molecular photoacoustic tomography of breast cancer using receptor targeted magnetic iron oxide nanoparticles as contrast agents.HER-2/neu targeted delivery of a nanoprobe enables dual photoacoustic and fluorescence tomography of ovarian cancer.Nanotheranostics of circulating tumor cells, infections and other pathological features in vivo In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells.Handheld miniature probe integrating diffuse optical tomography with photoacoustic imaging through a MEMS scanning mirror.Targeted nanoagents for the detection of cancers Aptamer-conjugated Magnetic Nanoparticles as Targeted Magnetic Resonance Imaging Contrast Agent for Breast Cancer.T₁-weighted ultrashort echo time method for positive contrast imaging of magnetic nanoparticles and cancer cells bound with the targeted nanoparticles.Peptides and peptide hormones for molecular imaging and disease diagnosis Detection of Cancer Metastases with a Dual-labeled Near-Infrared/Positron Emission Tomography Imaging Agent Sub-100nm gold nanomatryoshkas improve photo-thermal therapy efficacy in large and highly aggressive triple negative breast tumors Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models Theranostic nanoparticles carrying doxorubicin attenuate targeting ligand specific antibody responses following systemic delivery.Molecular magnetic resonance contrast agents for the detection of cancer: past and present.Tumor-targeted RNA-interference: functional non-viral nanovectors.Improved PET imaging of uPAR expression using new (64)Cu-labeled cross-bridged peptide ligands: comparative in vitro and in vivo studies.In vivo anti-metastatic effects of uPAR retargeted measles virus in syngeneic and xenograft models of mammary cancer A handheld fluorescence molecular tomography system for intraoperative optical imaging of tumor margins.Nanoparticle PEGylation for imaging and therapy.Improving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticles Nanotechnology for cancer treatment.Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery Dual actions of albumin packaging and tumor targeting enhance the antitumor efficacy and reduce the cardiotoxicity of doxorubicin in vivo.A pH-Responsive Drug-Delivery Platform Based on Glycol Chitosan-Coated Liposomes.Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances Preclinical evaluation of a urokinase plasminogen activator receptor-targeted nanoprobe in rhesus monkeys Specific detection of CD133-positive tumor cells with iron oxide nanoparticles labeling using noninvasive molecular magnetic resonance imaging.The effects of particle size, density and shape on margination of nanoparticles in microcirculation.Strategies for Target-Specific Contrast Agents for Magnetic Resonance Imaging Multimodal iron oxide nanoparticles for hybrid biomedical imaging.Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.Tumor-targeting multifunctional micelles for imaging and chemotherapy of advanced bladder cancer Targeted delivery of siRNA-generating DNA nanocassettes using multifunctional nanoparticles.Characterization of a murine xenograft model for contrast agent development in breast lesion malignancy assessment.

P2860

Q26828849-6BE025E7-F322-439F-80D3-6CD50182E7AC Q26865306-12FCEE3B-30C2-4436-A8D7-11A7DA41E47D Q28476700-0E9DD04D-97C7-4D94-B6E9-CCA9983A9344 Q30355600-D6C1BE7E-7EB0-42FC-AB33-2024AB817FD2 Q30381349-6E76D7D7-A604-493F-9DD6-B792E3C0DF31 Q30396675-608C3D58-4D25-466D-89D9-752524433FC9 Q30410360-EED6BA35-EDFA-424E-95E2-C0525E950261 Q30415480-A33C03CC-D067-486E-B809-905A01DFA13C Q30442087-12F29E1D-67BD-4CA1-A49D-CA94F5101117 Q30454393-79F2C588-6C58-4432-A4E6-CEE0BFCE9A99 Q30456261-47764976-AEC6-4775-956B-EF377BAF8ED4 Q30472641-179036BA-4701-4854-9193-44208B0C8F99 Q31151661-77953784-E2CD-45C8-AC98-CC2C3900EB4B Q33779313-C102E25B-7CCD-45A4-B4D9-FA490464A81F Q33846924-AC7B3EF9-FD8E-4D7F-8653-0B92064FC5FD Q34111208-4617C355-4630-41DD-88D8-5A41548363E5 Q34145579-3004558C-10CE-4EF2-ACF1-016C6C3A41AB Q34662745-977D8707-80C8-4868-BAB5-DD1B67EE4A6A Q34698633-C9118ED1-B0FE-4DE0-8F53-69E8F5E5FC52 Q34823410-B07A86B6-3EBA-4B63-B22A-7A700D2132D3 Q34974957-6E730DC0-F90B-4F92-B464-4538561E4EF8 Q34992753-3FF10AAC-587F-4334-84B6-80A4B7A35D87 Q34997475-4B5ED3CC-E40A-4A55-93DE-5C7D2E55A82F Q35533771-D21EDD94-4086-451B-B10F-13BCB7E7732D Q35553193-C9B23D8C-18C3-4804-93C7-8FFECAA38BCC Q35687164-EE7843EB-B8C1-45C5-8C53-0752D14BE895 Q35737878-EE0E52F1-6761-41A5-B10C-267732C5BB17 Q35809872-11020FCA-447E-4DD7-8C3E-4433DC8769A6 Q36010344-208D9DE7-7C9A-4FA4-8B9C-39A7551C40B5 Q36118061-E15746D3-AD4C-4483-AF08-7FF11DCF123A Q36157045-AF892719-B63D-4DCB-A05D-D8B9B5CEAF2A Q36240694-4906A8F3-4F37-4824-99EF-94CE31A06ABC Q36284380-47EE8224-3FF4-4A40-B52C-683E3F41911B Q36488910-19EBDCFF-57D1-4ABB-8F19-FFB81DB78AD4 Q36517070-E8F9F481-9A85-4865-86E1-8FCEA9BEBDBB Q36545276-98A9CD7C-7D7B-4B06-9916-D4F622CA2134 Q36721737-7E0613F1-E576-47F5-9E8A-27B7092D8EC6 Q36877731-BBB6F8B8-8E63-4090-8FF1-694817317CED Q36906374-6980B5B2-2341-420D-9FA9-F013E7E31EB5 Q36907393-E6DF7A56-472E-4050-BFE3-2388EA7B7210

P2860

Receptor-targeted nanoparticles for in vivo imaging of breast cancer.

http://www.wikidata.org/entity/Q37307237

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Receptor-targeted nanoparticles for in vivo imaging of breast cancer.

@en

Receptor-targeted nanoparticles for in vivo imaging of breast cancer.

@nl

type

label

Receptor-targeted nanoparticles for in vivo imaging of breast cancer.

@en

Receptor-targeted nanoparticles for in vivo imaging of breast cancer.

@nl

prefLabel

Receptor-targeted nanoparticles for in vivo imaging of breast cancer.

@en

Receptor-targeted nanoparticles for in vivo imaging of breast cancer.

@nl

P1433

Q37307237-10080519-D7D4-48C7-BE15-89418B5A4AF2

P1476

Q37307237-2129914B-1676-4787-B8D4-F3A3A812BC2F

P2093

Q37307237-187C6A87-9B3C-49FC-886D-7066318B99A7

Q37307237-1D779EC3-D5F8-460B-A67C-0536A5BFF96A

Q37307237-7191429E-78EA-4FEF-A4BE-29B67DE703DB

Q37307237-72DCBF82-35DE-4203-B735-59FF7C6E1EBF

Q37307237-9846CAE8-3DF4-40BF-9F9C-6A289B9294A9

Q37307237-A8B5E83C-EBBD-47B3-90C7-AB8153F66D03

Q37307237-C881C605-673D-47AF-970A-559326106283

Q37307237-D1083B38-D5C1-4EAD-BD0F-C5A9C979BC1B

Q37307237-D6C713B9-172A-4778-81E6-8DE53AAA1CEE

Q37307237-DD3B8CFF-9D09-4B35-9631-8D3E8656D1F1

P2860

Q37307237-023FED56-57C9-4504-B67C-B83DD86FA79F

Q37307237-0A6F119A-E072-4DFF-B6E5-47CAB85EF8C2

Q37307237-0E7593A4-F0A4-421F-AAA8-A81B0E926B54

Q37307237-1613C509-BA7F-4A4F-8DCB-77EF019E795B

Q37307237-1B1C0E10-07E8-4BDE-8847-0E68F6527052

Q37307237-1E95A60E-4236-4272-A89F-6743E36BD952

Q37307237-255C6B90-2608-4841-A965-425081CCE452

Q37307237-257B37FC-B88A-4D4C-A719-0DC21832419B

Q37307237-262F64E6-F2BE-4734-9786-15CDF128AAC9

Q37307237-3176CA2F-388B-49DE-9C39-D745290347C9

P304

Q37307237-5864CC2D-F158-409B-A4AC-BDC41EB6733A

P31

Q37307237-490E54DB-4B91-4C26-BCC5-51B4444B3398

P356

Q37307237-D5092BCB-E786-4F83-AF46-EB554D7FBD01

P407

Q37307237-92F2010C-B1AB-41B3-9B98-6A2A5597DFA0

P433

Q37307237-4287BD6C-157C-45CD-866B-8C0A8282999C

P478

Q37307237-172FA93B-720B-47A5-8CAC-B2AE9EB585A4

P577

Q37307237-1FD115B1-C28A-4A5E-A0D2-6CE25BFE93C5

P5875

Q37307237-040B8202-7DF5-477E-9EA6-FAFC13E0DBEF

P698

Q37307237-3CB3A99D-3695-4B33-9FF2-34E0D67319FF

P921

Q37307237-B4EA07B3-B0B5-40FB-AC99-1ABE7CFE7753

P932

Q37307237-491109FA-83AD-4CF7-B475-DCC5B8768FF0

P356

1078-0432.CCR-08-3289

P1433

Clinical Cancer Research

P1476

Receptor-targeted nanoparticles for in vivo imaging of breast cancer.

@en

P2093

Chunchun Ni

http://www.w3.org/2001/XMLSchema#string

Hui Mao

http://www.w3.org/2001/XMLSchema#string

Lily Yang

http://www.w3.org/2001/XMLSchema#string

Prasanthi Karna

http://www.w3.org/2001/XMLSchema#string

Shuming Nie

http://www.w3.org/2001/XMLSchema#string

William C Wood

http://www.w3.org/2001/XMLSchema#string

Xiang-Hong Peng

http://www.w3.org/2001/XMLSchema#string

Xiaohu Gao

http://www.w3.org/2001/XMLSchema#string

Xiaoxia Wang

http://www.w3.org/2001/XMLSchema#string

Xinjian Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

In vivo cancer targeting and imaging with semiconductor quantum dots

Biomimetic amplification of nanoparticle homing to tumors

Urokinase plasminogen activator receptor (CD87) expression of tumor-associated macrophages in ductal carcinoma in situ, breast cancer, and resident macrophages of normal breast tissue.

Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model.

Hepatic tumor imaging using iron oxide MRI: comparison with computed tomography, clinical impact, and cost analysis.

Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging.

uPAR: a versatile signalling orchestrator.

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.

P304

4722-4732

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-08-3289

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26653649

http://www.w3.org/2001/XMLSchema#string

P698

19584158

http://www.w3.org/2001/XMLSchema#string

P921

P932

2727672

http://www.w3.org/2001/XMLSchema#string